Category

news2

Filip Risteski, Chief Financial Officer at Biomapas

Biomapas appoints Chief Financial Officer

By | news2

Filip Risteski was recently appointed as Chief Financial Officer (CFO) at Biomapas and will be one of the key players further strengthening continued growth of Biomapas. Filip will report directly to Audrius Sveikata, Biomapas Chief Executive Officer. As a CFO he will be responsible for placing control over finance function and financial strategy, by maximizing efficiency and ensuring highest quality standards. Furthermore, Filip will work with a management team on implementation of overall company business strategy.

Read More
Monika Lakytė, HR Director at Biomapas

Biomapas appoints Director of Human Resources

By | news2

In order to support the continued growth of Biomapas, the company has appointed a Director of Human Resources, Monika Lakytė. “We are excited to have Monika as a member of our management team. She shares our values and our focus on future goals, her professional experience in recruitment process and personnel management will endorse our continued growth. People as Monika is the result of highest quality standards in our work,” said Juozas Buitkus, Biomapas COO.

Read More
Pharmacovigilance Brexit

Remaining Vigilant and Compliant after Brexit: What’s next? (Latest Updates)

By | news2

On 29th March 2017 UK submitted the notification of its intention to withdraw from the EU. This means that UK will become a ‘third country’ from 30th March’19. Even though leaving the EU with a deal remains the Government’s top priority, UK drug agency is publishing a series of guidance documents for industry and other stakeholders covering the proposed arrangements for the regulation of medicines, medical devices and clinical trials, if UK leaves EU with no deal.

Read More